Abstract |
|
Authors | Masahiro Ohgami, Takayuki Kaburagi, Atsuhiko Kurosawa, Masato Homma |
Journal | Lung cancer (Amsterdam, Netherlands)
(Lung Cancer)
Vol. 101
Pg. 9-10
(11 2016)
ISSN: 1872-8332 [Electronic] Ireland |
PMID | 27794414
(Publication Type: Case Reports, Journal Article)
|
Copyright | Copyright © 2016 Elsevier Ireland Ltd. All rights reserved. |
Chemical References |
- Cytochrome P-450 CYP1A2 Inducers
- Protein Kinase Inhibitors
- Phenytoin
- Erlotinib Hydrochloride
- Cytochrome P-450 CYP3A
- ErbB Receptors
|
Topics |
- Brain
(pathology)
- Brain Neoplasms
(complications, drug therapy, secondary)
- Carcinoma, Non-Small-Cell Lung
(complications, drug therapy, pathology, surgery)
- Cytochrome P-450 CYP1A2 Inducers
(blood, therapeutic use)
- Cytochrome P-450 CYP3A
(metabolism)
- Drug Interactions
- ErbB Receptors
(antagonists & inhibitors)
- Erlotinib Hydrochloride
(blood, therapeutic use)
- Female
- Humans
- Lung Neoplasms
(pathology)
- Middle Aged
- Phenytoin
(adverse effects, blood, therapeutic use)
- Protein Kinase Inhibitors
(adverse effects, therapeutic use)
- Seizures
(drug therapy, etiology)
- Treatment Outcome
|